Collateral susceptibility-guided alternation of ceftolozane/tazobactam with imipenem prevents resistance development in XDR Pseudomonas aeruginosa biofilms
Collateral susceptibility-guided alternation of ceftolozane/tazobactam with imipenem effectively prevented the selection of resistant mutants and thus could be a potential therapeutic strategy for the treatment of <i>P. aeruginosa</i> XDR chronic infections.
Authors
- María D. Macià (ORCID: https://orcid.org/0000-0001-5038-1356)
- Pablo A. Fraile-Ribot (ORCID: https://orcid.org/0000-0002-3822-9965)
- Óscar Murillo (ORCID: https://orcid.org/0000-0001-5776-8422)
- Elena Jordana‐Lluch (ORCID: https://orcid.org/0000-0002-1115-2048)
- Antonio Oliver (ORCID: https://orcid.org/0000-0001-9327-1894)
- Aina E. Llambías-Cabot
- Maria Antonia Gomis-Font (ORCID: https://orcid.org/0000-0001-6042-5674)
- María Fernández-Billón
- Rosa I Torrandell
- Pamela J. Colman-Vega
Institutions
- Instituto de Salud Carlos III (ES)
- Bellvitge University Hospital (ES)
- Institut d'Investigació Biomédica de Bellvitge (ES)
- Centro de Investigación Biomédica en Red (ES)
- Health Research Institute of the Balearic Islands (ES)
- Hospital Universitario Son Espases (ES)
Publication Details
- Journal
- Biofilm
- Published
- 2024-10-22
- DOI
- https://doi.org/10.1016/j.bioflm.2024.100231
- Citations
- 3
- Primary Topic
- Antibiotic Resistance in Bacteria
- Type
- article
- Field-Weighted Citation Impact
- 0.51
Funders
- Ministerio de Ciencia, Innovación y Universidades
- Ministerio de Ciencia e Innovación
- Instituto de Salud Carlos III